Evidence map›Paper›PMID 37258747›Full record

ReviewNature reviews. Gastroenterology & hepatology2023

A Roadmap for the Human Gut Cell Atlas.

Matthias Zilbauer, Kylie R James, Mandeep Kaur, Sebastian Pott, Zhixin Li, Albert Burger, Jay R Thiagarajah, Joseph Burclaff, Frode L Jahnsen, Francesca Perrone and 31 more

Abstract readReview
In one paragraph

Review in Nature reviews. Gastroenterology & hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Resolving cell lineages and gene functions in the developing mouse gastrointestinal tract using in utero transduction.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Climate Change, Epigenetics, Microbiota, and Health.International journal of environmental research and public health · 2026
    Review
  9. Article
  10. Review
  11. A Shared Framework for Gastrointestinal Organoid Research: It's Time.Cellular and molecular gastroenterology and hepatology · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors.

Matthias ZilbauerWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. mz304@cam.ac.uk.ORCID 0000-0002-7272-0547
Kylie R JamesGarvan Institute of Medical Research, Darlinghurst, NSW, Australia.ORCID 0000-0002-7107-0650
Mandeep KaurSchool of Molecular and Cell Biology, University of the Witwatersrand, Johannesburg, South Africa.ORCID 0000-0002-9757-4048
Sebastian PottSection of Genetic Medicine, Department of Medicine, University of Chicago, Chicago, IL, USA.ORCID 0000-0002-4118-6150
Zhixin LiDana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0001-9962-3942
Albert BurgerDepartment of Computer Science, Heriot-watt University, Edinburgh, UK.
Jay R ThiagarajahDivision of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-1437-325X
Joseph BurclaffJoint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University', Chapel Hill, NC, USA.ORCID 0000-0002-0325-5039
Frode L JahnsenDepartment of Pathology, Oslo University Hospital and University of Oslo, Oslo, Norway.
Francesca PerroneWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Alexander D RossWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Gianluca MatteoliTranslational Research Center for Gastrointestinal Disorders (TARGID), Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium.ORCID 0000-0002-2902-4976
Nathalie StakenborgTranslational Research Center for Gastrointestinal Disorders (TARGID), Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium.ORCID 0000-0002-6229-0045
Tomohisa SujinoCenter for the Diagnostic and Therapeutic Endoscopy, School of Medicine, Keio University, Tokyo, Japan.ORCID 0000-0003-0699-6577
Andreas MoorDepartment of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.ORCID 0000-0001-8715-8449
Raquel Bartolome-CasadoDepartment of Pathology, Oslo University Hospital and University of Oslo, Oslo, Norway.ORCID 0000-0002-8966-9047
Espen S BækkevoldDepartment of Pathology, Oslo University Hospital and University of Oslo, Oslo, Norway.
Ran ZhouSection of Genetic Medicine, Department of Medicine, University of Chicago, Chicago, IL, USA.ORCID 0000-0002-0562-4483
Bingqing XieDepartment of Medicine, University of Chicago, Chicago, IL, USA.
Ken S LauEpithelial Biology Center and Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA.ORCID 0000-0001-8438-0319
Shahida DinEdinburgh IBD Unit, Western General Hospital, NHS Lothian, Edinburgh, UK.ORCID 0000-0003-2855-3400
Scott T MagnessJoint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University', Chapel Hill, NC, USA.
Qiuming YaoDepartment of Computer Science and Engineering, University of Nebraska Lincoln, Lincoln, NE, USA.
Semir BeyazCold Spring Harbour Laboratory, Cold Spring Harbour, New York, NY, USA.
Mark ArendsDivision of Pathology, Centre for Comparative Pathology, Cancer Research UK Edinburgh Centre, Institute of Cancer and Genetics, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-6826-8770
Alexandre Denadai-SouzaLaboratory of Mucosal Biology, Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium.ORCID 0000-0003-0385-1321
Lori A CoburnVanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0003-3249-9806
Jellert T GaublommeDepartment of Biological Sciences, Columbia University, New York, NY, USA.
Richard BaldockUniversity of Edinburgh, Edinburgh, UK.ORCID 0000-0003-0332-6877
Irene PapatheodorouEuropean Molecular Biology Laboratory, European Bioinformatics Institute, EMBL-EBI, Wellcome Genome Campus, Hinxton, UK.ORCID 0000-0001-7270-5470
Jose Ordovas-MontanesDivision of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-5444-5601
Guy BoeckxstaensTranslational Research Center for Gastrointestinal Disorders (TARGID), Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium.ORCID 0000-0001-8267-5797
Anna HupalowskaGenentech, San Francisco, CA, USA.
Sarah A TeichmannWellcome Sanger Institute, Hinxton, UK.ORCID 0000-0002-6294-6366
Aviv RegevGenentech, San Francisco, CA, USA.
Ramnik J XavierBroad Institute and Department of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-5630-5167
Alison SimmonsMRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Michael P SnyderStanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0003-0784-7987
Keith T WilsonVanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0003-4421-1830
Gut Cell Atlas Consortium
Human Cell Atlas Gut Biological Network Consortium

Funding

Single-Cell Biology Shared ResourceP30CA045508 · NCI · COLD SPRING HARBOR LABORATORY · PI David A Tuveson · 1987 to 2026
$118.9M
PILOT AND FEASIBILITY STUDIESP30DK034987 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROBERT S. SANDLER · 1985 to 2026
$30.5M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MARY Kay WASHINGTON · 2002 to 2026
$29.9M
Tuft cell heterogeneity in function, lineage, and structure in ileal inflammatory diseaseR01DK103831 · NIDDK · VANDERBILT UNIVERSITY · PI LAU, KEN S · 2016 to 2024
$4.4M
Spermidine as a New Therapy for Colitis and Chemopreventive for Colitis-associated CarcinogenesisR01DK128200 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILSON, KEITH T. · 2021 to 2024
$2.7M
Genetic regulation of active and reserve intestinal stem cell statesR01DK115806 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MAGNESS, SCOTT T · 2019 to 2022
$1.5M
Dysregulated Polyamine Metabolism in H. pylori-associated Gastric Inflammation and Disease ProgressionI01CX002171 · VA · VETERANS HEALTH ADMINISTRATION · PI Keith T. Wilson · 2020 to 2026
–
CCL11 as a New Therapeutic Target for Colitis and Colon CancerI01BX004366 · VA · VETERANS HEALTH ADMINISTRATION · PI COBURN, LORI A · 2019 to 2022
–
BLRD VA I01 BX004366CSRD VA I01 CX002171Medical Research Council MC_PC_17230Medical Research Council MC_PC_MR/S025952/1Medical Research Council MC_UU_00008/7Medical Research Council MC_UU_00036/1Medical Research Council MC_UU_12010/7Medical Research Council MR/S036377/1Medical Research Council MR/T001917/1NCI NIH HHS P30 CA045508NIDDK NIH HHS P30 DK034987NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R01 DK103831NIDDK NIH HHS R01 DK115806NIDDK NIH HHS R01 DK128200Wellcome Trust
6 · The paper itself

Abstract

The number of studies investigating the human gastrointestinal tract using various single-cell profiling methods has increased substantially in the past few years. Although this increase provides a unique opportunity for the generation of the first comprehensive Human Gut Cell Atlas (HGCA), there remains a range of major challenges ahead. Above all, the ultimate success will largely depend on a structured and coordinated approach that aligns global efforts undertaken by a large number of research groups. In this Roadmap, we discuss a comprehensive forward-thinking direction for the generation of the HGCA on behalf of the Gut Biological Network of the Human Cell Atlas. Based on the consensus opinion of experts from across the globe, we outline the main requirements for the first complete HGCA by summarizing existing data sets and highlighting anatomical regions and/or tissues with limited coverage. We provide recommendations for future studies and discuss key methodologies and the importance of integrating the healthy gut atlas with related diseases and gut organoids. Importantly, we critically overview the computational tools available and provide recommendations to overcome key challenges.

Indexed as

Gastrointestinal TractOrganoidsForecastingHumans

Identifiers

PMID37258747
PMCPMC10527367

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.